Post by
Boomskid on Feb 24, 2023 2:13pm
Midatech Share Price Is Dropping
Midatech's share price has been dropping from 76.5¢ on February 9th, the day that Midatech announced its new financing at an initial proice of 58¢ per unit. As I write this, the Midatech share price is down 33% to 50.8¢.
The financing could be priced as low as 30¢ per unit dependent on share price. Dependent on certain shareholder approvals, certain aspects of the financing could be priced as low as 10¢ per unit. This would essentially wipe out current Midatech shareholders who would then have ~5% ownership of Midatech.
If there is a Bioasis deal coming with those almost worthless Midatech shares, then current Bioasis shareholders could end up with 2% or 3% of the resulting company, with no guarantee that the resulting company will retain much of any ownership of xB3.
By any definition, this would be a wiping out of Bioasis shareholder ownership of xB3.
Why is the Midatech share price dropping? Is it the market and the S&P Biotech EGF or might there be motive for others to do it?
jd
Comment by
prophetoffactz on Feb 24, 2023 3:10pm
"We all know he doesn't believe that the S&P Biotech market caused today's share price of 1.5¢." If BTI traded below cash, and it has none, given all the debt that it also has where would it be trading? It's a miracle it isn't trading at negative cents.
Comment by
Boomskid on Feb 24, 2023 3:38pm
poof says that it's a wonder that BTI isn't "trading at negative cents." If you have any shares, poof, I'll take them off your hands if you pay me 1.5¢ for each one. jd
Comment by
ROSIE2023 on Feb 24, 2023 3:21pm
I don't believe based on what has been stated , the midatech options are dead in the water they don't have the authorization to pursue a deal without shareholder approval am I correct ?